Asset Details
Do you wish to reserve the book?
Global, regional, and national burdens of vaccine-preventable infectious diseases with high incidence among middle-aged and older adults aged 55–89 years from 1990 to 2021: Results from the global burden of disease study 2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Global, regional, and national burdens of vaccine-preventable infectious diseases with high incidence among middle-aged and older adults aged 55–89 years from 1990 to 2021: Results from the global burden of disease study 2021
Do you wish to request the book?
Global, regional, and national burdens of vaccine-preventable infectious diseases with high incidence among middle-aged and older adults aged 55–89 years from 1990 to 2021: Results from the global burden of disease study 2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Global, regional, and national burdens of vaccine-preventable infectious diseases with high incidence among middle-aged and older adults aged 55–89 years from 1990 to 2021: Results from the global burden of disease study 2021
2025
Overview
To evaluate the global, regional, and national burden of four vaccine preventable infectious diseases (VPDs) among adults aged 55–89 years from 1990 to 2021, in the context of an aging population.
Data from the Global Burden of Disease Study 2021 on acute hepatitis A, B, E, and varicella and herpes zoster were analysed for incidence rates and disability-adjusted life years (DALYs), stratified by sex, age, Social Development Index (SDI), and region. Joinpoint regression analysis was used to assess trends.
In 2021, the global incidence of four VPDs among adults aged 55–89 years was 1698.8 cases per 100,000 population, with a total of 25,243,776 (95 % UI 17301929–34,959,277) new cases and 719,888 (95 % UI 534782–992,800) DALYs. From 1990 to 2021, the incidence rates of acute hepatitis A and acute hepatitis B consistently declined, whereas those of acute hepatitis E, varicella and herpes zoster moderately increased, with EAPCs of 0.13 (95 % UI 0.12–0.15) and 0.14 (95 % UI 0.09–0.19), respectively. In 2021, sub-Saharan Africa had the highest overall burden of the four diseases, whereas high-income Asia Pacific (945.7 per 100,000 population) and Western Europe (840.7 per 100,000 population) had the highest incidence rates of varicella and herpes zoster. Acute hepatitis A and acute hepatitis B were more prevalent in low- and middle-SDI regions, whereas increasing trends for acute hepatitis E and varicella and herpes zoster were observed in higher-SDI regions. The incidence rates of acute hepatitis A and acute hepatitis B were higher in males than in females and decreased with age.
Despite overall declines in VPDs among older adults, disparities remain. Public health efforts must focus on improving vaccine access and targeting at-risk populations, especially older adults, to address the burden of VPDs.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Adults
/ Age
/ Aged
/ Aging
/ Asia
/ Chickenpox - prevention & control
/ Disability-Adjusted Life Years
/ Female
/ Fever
/ Hepatitis A - prevention & control
/ Hepatitis B - prevention & control
/ Hepatitis E - prevention & control
/ Herpes Zoster - epidemiology
/ Herpes Zoster - prevention & control
/ Humans
/ Male
/ Trends
/ Typhoid
/ Vaccine-Preventable Diseases - epidemiology
/ Vaccine-Preventable Diseases - prevention & control
/ Vaccines
